-
Updates in Email
Novartis case: Supreme Court’s historic decision on Section 3(d)
After 2005 India started granting product patents on medicines. However, Section 3(d), one of the safeguards introduced by Parliament, seeks to prevent patenting of new forms of known substances unless they exhibit enhanced efficacy. ... Read More...
-
Like US on Facebook
News Articles
- Indian Patent Law TRIPS Compliant: Novartis judgment shows the way
- Why Novartis case will help innovation
- India’s patent case victory rattles Big Pharma
- Novartis Ruling Reverberates Past India's Borders
- India’s Patently Wise Decision
- The hypocrisy of Novartis
- Novartis denied cancer drug patent in landmark Indian case
